Patent · US Active

Determination of miR-423-5p in heart failure

US10913979B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2015
Grant dateFeb 9, 2021
Priority date
Expiry dateMay 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods, kits and uses for diagnosing heart failure using miRNA-biomarker from blood.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.